Intouch Solutions

APRIL 11, 2024

With today’s current possibilities, there is still so much more on the horizon for precision engagement, especially when combining it with the new and revolutionary Generative Pre-trained Transformers Artificial Intelligence (GPT AI). So, what is precision engagement? How is AI being used in precision engagement?

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Engagement channels. Virtual connections. Joanna Carlish.

Regulation 97

Regulation Marketing Sales Branding 97

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Although COVID-19 has slowed the growth of drug sales, the oncology market’s total growth is driven by the targeted drugs in oncology. ” The U.S.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

pharmaphorum

APRIL 5, 2022

The therapy is a bispecific T cell engager (BiTE) molecule, consisting of a soluble TCR targeting gp100 expressed on cancer cells fused to a protein that binds CD3 receptors on lymphocytes. It’s the first treatment for mUM in the EU, as well as the first BiTE drug to treat a solid tumour. ” Image by Pexels from Pixabay .

Protein 52

Protein Sales Drugs Trials 52

pharmaphorum

JUNE 2, 2022

In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceutical companies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. By 2026, this would mean that orphan drug sales will account for 20% of all prescription drug sales. Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

DECEMBER 17, 2021

Aduhelm (aducanumab) was approved by the FDA in June, but has been held back by a glacial rollout as clinicians have questioned the data on which the decision to clear the drug was based, plus a $56,000 per year price tag, which has in turn led to pushback by payers.

Trials 52

Trials Sales Marketing FDA Approval 52

pharmaphorum

SEPTEMBER 15, 2020

This gives them huge amounts of customer data that allows them to shape and personalise the way they engage with their customers, not least thanks to the direct-to-consumer sales model they often offer. Jeremy Richter, Tag. Build on the rapid responses to COVID-19.

Branding 129

Branding Marketing Pharma Companies Life Science 129